A detailed history of D. E. Shaw & Co., Inc. transactions in Ascendis Pharma A/S stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 281,537 shares of ASND stock, worth $35.6 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
281,537
Previous 340,118 17.22%
Holding current value
$35.6 Million
Previous $51.4 Million 25.32%
% of portfolio
0.04%
Previous 0.05%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$121.07 - $153.67 $7.09 Million - $9 Million
-58,581 Reduced 17.22%
281,537 $38.4 Million
Q1 2024

May 15, 2024

BUY
$123.45 - $159.4 $9.25 Million - $11.9 Million
74,961 Added 28.27%
340,118 $51.4 Million
Q4 2023

Feb 14, 2024

BUY
$86.1 - $127.36 $3.84 Million - $5.68 Million
44,604 Added 20.22%
265,157 $33.4 Million
Q3 2023

Nov 14, 2023

BUY
$86.5 - $103.97 $7.65 Million - $9.2 Million
88,470 Added 66.98%
220,553 $20.7 Million
Q2 2023

Aug 14, 2023

SELL
$69.96 - $97.84 $499,024 - $697,892
-7,133 Reduced 5.12%
132,083 $11.8 Million
Q1 2023

May 15, 2023

BUY
$104.9 - $126.78 $2.36 Million - $2.85 Million
22,512 Added 19.29%
139,216 $14.9 Million
Q4 2022

Feb 14, 2023

BUY
$99.42 - $131.97 $2.47 Million - $3.29 Million
24,894 Added 27.11%
116,704 $14.3 Million
Q3 2022

Nov 14, 2022

SELL
$84.03 - $110.23 $669,887 - $878,753
-7,972 Reduced 7.99%
91,810 $9.48 Million
Q2 2022

Aug 15, 2022

SELL
$78.08 - $117.61 $4.07 Million - $6.14 Million
-52,177 Reduced 34.34%
99,782 $9.28 Million
Q1 2022

May 16, 2022

SELL
$102.18 - $135.75 $271,900 - $361,230
-2,661 Reduced 1.72%
151,959 $17.8 Million
Q4 2021

Feb 14, 2022

BUY
$127.1 - $169.66 $16.5 Million - $22 Million
129,793 Added 522.79%
154,620 $20.8 Million
Q3 2021

Nov 15, 2021

BUY
$112.67 - $176.92 $2.11 Million - $3.31 Million
18,710 Added 305.87%
24,827 $3.96 Million
Q2 2021

Aug 16, 2021

SELL
$121.62 - $145.29 $273,645 - $326,902
-2,250 Reduced 26.89%
6,117 $805,000
Q1 2021

May 17, 2021

SELL
$124.92 - $173.33 $1.78 Million - $2.47 Million
-14,241 Reduced 62.99%
8,367 $1.08 Million
Q4 2020

Feb 16, 2021

BUY
$151.2 - $182.76 $943,941 - $1.14 Million
6,243 Added 38.15%
22,608 $3.77 Million
Q3 2020

Nov 16, 2020

SELL
$134.29 - $154.32 $507,750 - $583,483
-3,781 Reduced 18.77%
16,365 $2.53 Million
Q2 2020

Aug 14, 2020

BUY
$110.87 - $156.01 $16,297 - $22,933
147 Added 0.74%
20,146 $2.98 Million
Q1 2020

May 15, 2020

BUY
$97.01 - $145.11 $1.72 Million - $2.58 Million
17,750 Added 789.24%
19,999 $2.25 Million
Q4 2019

Feb 14, 2020

SELL
$91.45 - $139.12 $1.15 Million - $1.75 Million
-12,573 Reduced 84.83%
2,249 $313,000
Q3 2019

Nov 14, 2019

SELL
$95.8 - $118.9 $207,215 - $257,180
-2,163 Reduced 12.73%
14,822 $1.43 Million
Q2 2019

Aug 14, 2019

SELL
$107.11 - $132.09 $25.8 Million - $31.9 Million
-241,192 Reduced 93.42%
16,985 $1.96 Million
Q1 2019

May 15, 2019

BUY
$62.15 - $129.99 $13.2 Million - $27.6 Million
211,996 Added 459.05%
258,177 $30.4 Million
Q4 2018

Feb 14, 2019

BUY
$55.16 - $69.67 $324,395 - $409,729
5,881 Added 14.59%
46,181 $2.89 Million
Q3 2018

Nov 14, 2018

BUY
$63.77 - $76.28 $1.3 Million - $1.55 Million
20,377 Added 102.28%
40,300 $2.86 Million
Q2 2018

Aug 14, 2018

BUY
$58.55 - $73.92 $842,007 - $1.06 Million
14,381 Added 259.49%
19,923 $1.33 Million
Q1 2018

May 15, 2018

BUY
$38.98 - $68.04 $216,027 - $377,077
5,542 New
5,542 $362,000

Others Institutions Holding ASND

About Ascendis Pharma A/S


  • Ticker ASND
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,810,200
  • Market Cap $7.06B
  • Description
  • Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...
More about ASND
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.